Future vision for the quality assurance of oncology clinical trials
Thomas J. FitzGerald(University of Massachusetts Chan Medical School), Marcia Urie(Providence College), Michael V. Knopp(University of California, Los Angeles), Walter J. Curran(Piedmont Cancer Institute), D Followill(The University of Texas MD Anderson Cancer Center), Jeff M. Michalski(Washington University in St. Louis), James M. Galvin(Thomas Jefferson University), Lawrence H. Schwartz(Memorial Sloan Kettering Cancer Center), Richard Hanusik, Maryann Bishop‐Jodoin(Health Insurance Review and Assessment Service), Joel Saltz(Stony Brook Medicine), Walter Bosch(Washington University in St. Louis), Mitchell D. Schnall(California University of Pennsylvania), Ying Xiao(Economic Research Institute), Steven R. King(Texas Tech University), Fran Laurie(University of Massachusetts Chan Medical School), Elizabeth O’Meara(RTOG Foundation), Kenneth Ulin(University of Massachusetts Chan Medical School)
Cited by 42
Related Papers
The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)
|IEEE Transactions on Medical Imaging|2014|6.7k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
|New England Journal of Medicine|2014|2.8k
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
|CA A Cancer Journal for Clinicians|2007|2.6k